Naito S, Kuroiwa Y, Itoyama T, Tsubaki T, Horikawa A, Sasazuki T, Noguchi S, Ohtsuki S, Tokuomi H, Miyatake T, Takahata N, Kawanami S
Tissue Antigens. 1978 Jul;12(1):19-24.
Determination of HLA-A, -B and -C types in 43 Japanese patients with multiple sclerosis (MS) and of DR type in 25 MS patients was carried out using antisera from the 7th International Histocompatibility Workshop. The results were compared with 46 controls typed simultaneously. Twenty-three patients were also tested for HLA-Dw2. The conclusions were: 1) There were no significantly higher occurrences of HLA-A3, B7, Dw2 or DRw2 in Japanese MS. 2) Japanese MS might nevertheless be associated with the human major histocompatibility complex, because HLA-B40 was significantly less frequent in MS and two anti HLA-DRw sera, 7w008 and 034, reacted positively more often against lymphocytes from MS patients.
使用来自第七届国际组织相容性研讨会的抗血清,对43例日本多发性硬化症(MS)患者进行了HLA - A、- B和 - C分型检测,并对25例MS患者进行了DR分型检测。将结果与同时进行分型的46例对照进行比较。还对23例患者进行了HLA - Dw2检测。结论如下:1)在日本MS患者中,HLA - A3、B7、Dw2或DRw2的出现频率没有显著升高。2)然而,日本MS可能与人类主要组织相容性复合体有关,因为HLA - B40在MS患者中明显较少见,并且两种抗HLA - DRw血清7w008和034对MS患者淋巴细胞的阳性反应更频繁。